Nu Skin Enterprises Inc (NUS)
Official siteCONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE
Market Cap: $196.17M
Last updated: Nov 17, 2026 at 11:06 AM ET
Nu Skin Enterprises Inc (NUS) Financials: Revenue, Profit and Cash Flow
Nu Skin Enterprises reported revenue of $1.49B for the fiscal year ended Dec 31, 2025, down 14.3% from the year before. That year, net income was $160.20M with a net margin of 10.8%, operating cash flow was $80.29M and free cash flow was $46.01M. The quarter ended Sep 30, 2026 had revenue of $311.01M and net income of -$742.00K.
Revenue and Margins
The operating margin was 4.4% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue fell from $2.21B, a compound annual decline of 4.3%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $1.49B | -14.3% | 69.4% | 4.4% | 10.8% |
| Dec 2024 | $1.73B | -12.0% | 68.2% | -8.8% | -8.5% |
| Dec 2023 | $1.97B | -11.5% | 68.9% | 2.5% | 0.4% |
| Dec 2022 | $2.23B | -17.4% | 71.7% | 5.0% | 4.7% |
| Dec 2021 | $2.70B | +4.4% | 75.0% | 8.7% | 5.5% |
| Dec 2020 | $2.58B | +6.7% | 74.5% | 10.0% | 7.4% |
| Dec 2019 | $2.42B | -9.7% | 76.0% | 11.0% | 7.2% |
| Dec 2018 | $2.68B | +17.5% | 76.3% | 9.0% | 4.5% |
| Dec 2017 | $2.28B | +3.2% | 78.0% | 12.0% | 5.7% |
| Dec 2016 | $2.21B | N/A | 77.3% | 10.5% | 6.5% |
Income Statement
In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, the company posted a net loss after a profit in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B | $2.58B | $2.42B | $2.68B | $2.28B | $2.21B |
| Cost of revenue | $453.76M | $550.23M | $611.85M | $630.91M | $675.22M | $658.03M | $581.42M | $634.14M | $502.08M | $500.46M |
| Gross profit | $1.03B | $1.18B | $1.36B | $1.59B | $2.02B | $1.92B | $1.84B | $2.04B | $1.78B | $1.71B |
| Operating income | $65.76M | -$151.59M | $48.27M | $110.85M | $233.99M | $257.56M | $267.43M | $240.86M | $274.48M | $231.10M |
| Net income | $160.20M | -$146.59M | $8.60M | $104.78M | $147.27M | $191.35M | $173.55M | $121.89M | $129.44M | $143.09M |
| EBITDA | $262.41M | -$78.83M | $123.06M | $174.97M | $308.78M | $330.22M | $331.82M | $302.67M | $337.13M | $285.24M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $311.01M | $320.11M | $320.61M | $370.32M | $364.21M | $386.14M | $364.49M | $445.55M | $430.14M | $439.08M | $417.31M | $488.64M |
| Gross profit | $202.17M | $218.32M | $214.46M | $261.98M | $256.72M | $265.73M | $246.96M | $279.15M | $301.46M | $307.18M | $294.06M | $352.43M |
| Operating income | $5.09M | -$59.32M | $4.03M | $23.24M | $21.64M | $30.78M | -$9.90M | -$53.08M | $18.23M | -$125.56M | $8.82M | $16.06M |
| Net income | -$742.00K | -$249.80M | $1.84M | $14.49M | $17.08M | $21.12M | $107.52M | -$36.10M | $8.30M | -$118.26M | -$533.00K | $7.28M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded total debt of $224.19M by $14.44M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.41B | $1.47B | $1.81B | $1.82B | $1.91B | $1.96B | $1.77B | $1.69B | $1.59B | $1.47B |
| Current assets | $547.70M | $538.60M | $701.87M | $759.87M | $872.95M | $903.20M | $740.17M | $799.24M | $777.79M | $714.34M |
| Cash and equivalents | $238.63M | $186.88M | $256.06M | $264.73M | $339.59M | $402.68M | $335.63M | $386.91M | $426.40M | $357.25M |
| Total liabilities | $600.07M | $817.46M | $986.66M | $923.67M | $993.71M | $1.06B | $893.72M | $912.58M | $885.28M | $809.98M |
| Short-term debt | $20.00M | $30.00M | $25.00M | $25.00M | $107.50M | $30.00M | $27.50M | $69.45M | $77.84M | $82.73M |
| Long-term debt | $204.19M | $363.61M | $478.04M | $377.47M | $268.78M | $305.39M | $334.46M | $361.01M | $310.79M | $334.17M |
| Shareholder equity | $805.24M | $651.46M | $821.97M | $897.30M | $912.77M | $894.27M | $875.29M | $781.87M | $704.60M | $664.07M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.09B | $1.12B | $1.38B | $1.41B | $1.42B | $1.44B | $1.39B | $1.47B | $1.58B | $1.59B | $1.74B | $1.81B |
| Total liabilities | $540.60M | $578.79M | $582.71M | $600.07M | $624.61M | $655.94M | $637.44M | $817.46M | $876.02M | $899.81M | $931.71M | $986.66M |
| Cash and equivalents | $164.90M | $189.64M | $198.65M | $238.63M | $251.79M | $264.16M | $203.77M | $186.88M | $227.75M | $224.25M | $212.53M | $256.06M |
| Shareholder equity | $547.48M | $542.74M | $794.09M | $805.24M | $799.79M | $787.75M | $753.97M | $651.46M | $706.88M | $686.16M | $810.21M | $821.97M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 57.3% of operating cash flow. Dividends and share repurchases together came to 69.3% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $80.29M | $111.74M | $118.64M | $108.06M | $141.58M | $379.14M | $177.93M | $202.74M | $302.56M | $275.26M |
| Capital expenditures | $34.28M | $41.58M | $58.49M | $59.06M | $68.61M | $63.82M | $66.07M | $70.37M | $60.16M | $50.22M |
| Free cash flow | $46.01M | $70.16M | $60.15M | $49.01M | $72.97M | $315.32M | $111.86M | $132.37M | $242.40M | $225.04M |
| Dividends paid | $11.83M | $11.93M | $77.62M | $77.02M | $76.27M | $78.39M | $82.19M | $80.58M | $76.06M | $78.44M |
| Share repurchases | $20.04M | $0 | $13.01M | $70.05M | $80.42M | $144.33M | $825.00K | $69.56M | $71.73M | $247.21M |
| Investing cash flow | $170.66M | -$37.96M | -$134.50M | -$67.08M | -$88.73M | -$79.43M | -$71.41M | -$108.76M | -$91.96M | -$57.86M |
| Financing cash flow | -$202.40M | -$133.18M | $10.73M | -$99.50M | -$104.70M | -$245.17M | -$154.79M | -$116.71M | -$159.57M | -$134.71M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$8.12M | $10.63M | -$3.92M | $16.62M | $27.48M | $35.80M | $389.00K | $25.79M | $31.43M | $51.21M | $3.32M | $54.17M |
| Capital expenditures | $11.35M | $5.64M | $13.71M | $10.76M | $9.91M | $18.00K | $13.58M | $12.58M | $8.60M | $8.12M | $12.28M | $20.39M |
| Free cash flow | -$19.47M | $4.99M | -$17.63M | $5.86M | $17.57M | $35.78M | -$13.20M | $13.20M | $22.84M | $43.08M | -$8.96M | $33.78M |
Frequently Asked Questions About NUS
What is Nu Skin Enterprises' annual revenue?
Nu Skin Enterprises reported revenue of $1.49B for the fiscal year ended Dec 31, 2025.
How fast is Nu Skin Enterprises' revenue growing?
Revenue was down 14.3% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -12.6%.
Is Nu Skin Enterprises profitable?
Yes. Nu Skin Enterprises reported net income of $160.20M for the fiscal year ended Dec 31, 2025, with a net margin of 10.8%.
How much free cash flow does NUS generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $80.29M minus capital expenditures of $34.28M produced free cash flow of $46.01M.
How much debt does Nu Skin Enterprises have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $204.19M, short-term debt of $20.00M and cash and equivalents of $238.63M.
NUS pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors